The US FDA has not yet found an association between oral bisphosphonates and the risk of atypical subtrochanteric femur fractures,

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2010年 / 1293卷 / 1期
关键词：
Public Health; Clinical Trial; Osteoporosis; Bisphosphonates; Healthcare Professional;
D O I：
10.2165/00128415-201012930-00004
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 31 条
  • [11] Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry
    Young-Kyun Lee
    Dong Won Byun
    Sung-Mok Jung
    Hye-Young Kwon
    Ha-Young Kim
    Se Hwa Kim
    Tae-Young Kim
    Sunmee Jang
    Yong-Chan Ha
    Calcified Tissue International, 2019, 104 : 313 - 319
  • [12] Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry
    Lee, Young-Kyun
    Byun, Dong Won
    Jung, Sung-Mok
    Kwon, Hye-Young
    Kim, Ha-Young
    Kim, Se Hwa
    Kim, Tae-Young
    Jang, Sunmee
    Ha, Yong-Chan
    CALCIFIED TISSUE INTERNATIONAL, 2019, 104 (03) : 313 - 319
  • [13] Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries
    Wang, Z.
    Ward, M. M.
    Chan, L.
    Bhattacharyya, T.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (08) : 2109 - 2116
  • [14] Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries
    Z. Wang
    M. M. Ward
    L. Chan
    T. Bhattacharyya
    Osteoporosis International, 2014, 25 : 2109 - 2116
  • [15] Oral Bisphosphonates Are Associated with Increased Risk of Atypical Femoral Fractures in Elderly Women
    Erviti, Juan
    Oliva, Belen
    Alonso, Alvaro
    Gorricho, Javier
    Lopez, Antonio
    Timoner, Julia
    Huerta, Consuelo
    Gil, Miguel
    De Abajo, Francisco
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S29 - S29
  • [16] FDA Statement on Relationship Between Bisphosphonate Use and Atypical Subtrochanteric and Femoral Shaft Fractures: A Considered Opinion
    Rogers, Lee F.
    Taljanovic, Mihra
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (03) : 563 - 566
  • [17] Association between alendronate and atypical femur fractures: a meta-analysis
    Liu, Lu
    Li, Chunyan
    Yang, Peng
    Zhu, Jian
    Gan, Dongmei
    Bu, Le
    Zhang, Manna
    Sheng, Chunjun
    Li, Hong
    Qu, Shen
    ENDOCRINE CONNECTIONS, 2015, 4 (01):
  • [18] EXPLORING DIFFERENCES IN BONE DENSITY AND STRUCTURE BETWEEN PATIENTS ON BISPHOSPHONATES WITH ATYPICAL FEMUR FRACTURES AND OTHER POPULATIONS
    Cheung, Angela
    Bogoch, Earl
    Khan, Aliya
    Adachi, Jonathan
    Josse, Robert
    Bleakney, Robert
    Veillette, Christian
    Kapral, Moira
    McDonald-Blumer, Heather
    Ridout, Rowena
    Cardew, Savannah
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 351 - 352
  • [19] Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study
    Erviti, Juan
    Alonso, Alvaro
    Oliva, Belen
    Gorricho, Javier
    Lopez, Antonio
    Timoner, Julia
    Huerta, Consuelo
    Gil, Miguel
    De Abajo, Francisco
    BMJ OPEN, 2013, 3 (01):
  • [20] Association between fracture type and the risk of bleeding in intertrochanteric femur fractures
    Dogan, Necati
    Yildirim, Cem
    Palit, Fatih
    JOURNAL OF ORTHOPAEDICS, 2022, 33 : 66 - 69
1234